77 results
8-K
EX-10.1
EQRX
EQRx, Inc.
9 Nov 23
Completion of Acquisition or Disposition of Assets
9:29am
of the nature of such claim and the date on which such claim is requested to be paid. The Company shall respond to the Executive within thirty (30) days
8-K
EX-3.2
EQRX
EQRx, Inc.
9 Nov 23
Completion of Acquisition or Disposition of Assets
9:29am
for indemnification set forth in the DGCL.
(g) Contractual Nature of Rights.
(i) The provisions of this Section 8.2 shall be deemed to be a contract between
DEFA14A
EQRX
EQRx, Inc.
1 Nov 23
Additional proxy soliciting materials
8:02am
, (iii) the lack of specificity of the October 26th Proposal on terms other than the proposed exchange ratio, (iv) the preliminary nature
425
EQRX
EQRx, Inc.
1 Nov 23
Business combination disclosure
7:59am
, (iv) the preliminary nature and conditionality of the October 26th Proposal, (v) developments in Revolution Medicines’ business and clinical
8-K
4rxrcyfvdnkk6bbkl
1 Nov 23
Other Events
7:57am
425
hqxk6y xdpbjt8yfc
23 Oct 23
Business combination disclosure
6:13am
DEFM14A
zkxak5
29 Sep 23
Proxy related to merger
4:38pm
425
e8qn8 ndv5
1 Aug 23
Business combination disclosure
5:22pm
425
iji8oeqj drhxkypdw
1 Aug 23
Business combination disclosure
7:25am
8-K
EX-2.1
brmnt9e
1 Aug 23
Form of Parent Stockholder Voting Agreement
7:19am
425
vpgecggg5 bp6
1 Aug 23
Business combination disclosure
7:15am
424B3
7iqu3j9
10 Nov 22
Prospectus supplement
7:24pm
DEF 14A
mm0t a532ax
12 Aug 22
Definitive proxy
4:05pm
424B3
w3v9un3yx3n
11 Aug 22
Prospectus supplement
9:21pm
424B3
u4uk6 damr
13 May 22
Prospectus supplement
5:24pm